No. 1 Jin Yuan Road
Daxing Industrial Development Zone
Beijing 102600
Contact: Yongqing Cheng, CEO
Tel: +86-10-6125-3306 ext. 201 
Email:   
Website: www.triprime.com

Beijing Tri-Prime Genetic Engineering Co., Ltd. (“Tri-Prime”) was established in 1992 and now it was a fully integrated biopharmaceutical enterprise with about 200 employees.

The company's significant milestones include:

Pioneer development of biopharmaceutical products and processes from laboratory to commercial scales;
Navigating the Chinese regulatory and legal systems to obtain approval;
Out-licensed nine biologics to a range of biotech companies to jump start the industry, which consists 50% of total biologic sales in today's Chinese market;
Setting up the first Chinese GMP standards for biopharmaceutical product manufacturing; Standardized the Chinese interferon market by applying modern marketing strategies and techniques;
Successfully steering the ever-changing Chinese distribution system, then competing and winning a fierce price war in a biogeneric market – Tri-Prime climbed to the top in market shares in the interferon maker by 2005Q1, despite a few years late to the market.